- Published
- Nov 3, 2026
- Respond by
- Dec 10, 2026, 14:00Closes in 20 days
- Latest amendment
- Nov 13, 20261 amendment
Procurement
- Procurement type
- Request for Proposal
- Procurement method
- Competitive - Open bidding
- Selection criteria
- Lowest Price
- Category
- Services
- Jurisdiction
- Federal
- Region of delivery
- South Korea
- Chile
- United States of America
- +6 more
- Region of opportunity
- National Capital Region (NCR)
Not stated in the notice: expected contract period, end user
See how this opportunity fits your company
Create a free account and describe your company. With the trial, CanPursue checks every opportunity against it and explains the fit.
Create free accountDescription
The Mechanistic Studies Division (MSD) of Health Canada’s Environmental Health Research and Science Bureau investigates the pathways by which physical, chemical and microbiological agents can cause adverse health effects. To determine how chemical substances cause DNA damage that can lead to illnesses like cancer or inherited diseases, MSD requires high-throughput genome sequencing services utilizing Illumina and Pacific Biosciences (PacBio) platforms.
The primary objective of this contract is to secure long-term high-quality sequencing services for pre-prepared DNA libraries and genomic DNA and/or RNA utilizing Illumina or PacBio Revio platforms for the full duration of projects funded until up to 2030-2031.
This requirement encompasses the sequencing of multiple mouse and human error-corrected next-generation sequencing (ecNGS) DNA libraries, genomic DNA and/or RNA samples in direct support of four distinct research projects. These projects are distributed across the Division and funded through three separate programs. Collectively, they employ advanced genomic technologies to support public health protection by identifying environmental mutagens,
evaluating occupational hazards, and improving toxicological testing methodologies.
Specifically, this work will use ecNGS, whole-genome sequencing (WGS), whole-exome sequencing and/or RNA-sequencing approaches to detect and characterize both spontaneous mutations and mutations induced by chemical and environmental exposures in mouse and human DNA as well as gene expression changes. The resulting data will contribute to a better
understanding of mutagenic mechanisms, exposure-related genetic damage, and the development of more sensitive and informative approaches for genetic toxicology and human health risk assessment.
Source
Open official sourceVerify the notice and download the full solicitation on the official page.
- Source
- CanadaBuys
- Solicitation
- 1000273702
- Reference number
- cb-321-95217286
- Observed
- Nov 19, 2026